Daniel James George, MD

Professor of Medicine
Professor in Surgery
Member of the Duke Cancer Institute
Campus mail Duke Box 103861, Durham, NC 27710
Phone (919) 668-4615
Email address daniel.george@duke.edu

Education and Training

  • Fellow in Medical Oncology, Medicine, Johns Hopkins University, 1995 - 1998
  • Medical Resident, Medicine, Johns Hopkins University, 1992 - 1995
  • M.D., Duke University, 1992

Grants

Publications

Paller, Channing J., Emmanuel S. Antonarakis, Tomasz M. Beer, Hala T. Borno, Maria I. Carlo, Daniel J. George, Julie N. Graff, et al. “Germline Genetic Testing in Advanced Prostate Cancer; Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium.” Clin Genitourin Cancer 17, no. 4 (August 2019): 275-282.e1. https://doi.org/10.1016/j.clgc.2019.04.013.

PMID
31171481
Full Text

Tucker, Matthew D., Jason Zhu, Daniele Marin, Rajan T. Gupta, Santosh Gupta, William R. Berry, Sundhar Ramalingam, et al. “Pembrolizumab in men with heavily treated metastatic castrate-resistant prostate cancer.” Cancer Med 8, no. 10 (August 2019): 4644–55. https://doi.org/10.1002/cam4.2375.

PMID
31270961
Full Text

Griffith, Sandra D., Rebecca A. Miksad, Geoff Calkins, Paul You, Nicole G. Lipitz, Ariel B. Bourla, Erin Williams, et al. “Characterizing the Feasibility and Performance of Real-World Tumor Progression End Points and Their Association With Overall Survival in a Large Advanced Non-Small-Cell Lung Cancer Data Set.” Jco Clin Cancer Inform 3 (August 2019): 1–13. https://doi.org/10.1200/CCI.19.00013.

PMID
31403818
Full Text

McNamara, Megan Ann, Taofik Oyekunle, Bennett B. Chin, Jorge Oldan, Aseem Anand, Michala Ritz, Lindsey Shantzer, Monika Anand, Andrew J. Armstrong, and Daniel J. George. “Patterns of response and progression in bone and soft tissue during and after treatment with radium-223 for metastatic castrate-resistant prostate cancer.” Prostate 79, no. 10 (July 2019): 1106–16. https://doi.org/10.1002/pros.23822.

PMID
31045266
Full Text

George, Daniel J. “Treatment options for patients with prostate cancer who develop metastatic disease after hormonal therapy.” Clin Adv Hematol Oncol 17, no. 7 (July 2019): 382–85.

PMID
31449503
Scholars@Duke

George, D. J. “Caring for every patient, learning from every patient.” Clinical Advances in Hematology and Oncology 17, no. 7 (July 1, 2019).

Scholars@Duke

Pal, Sumanta, Jun Gong, Shivani K. Mhatre, Shih-Wen Lin, Andy Surinach, Sarika Ogale, Rini Vohra, Herschel Wallen, and Daniel George. “Real-world treatment patterns and adverse events in metastatic renal cell carcinoma from a large US claims database.” Bmc Cancer 19, no. 1 (June 7, 2019): 548. https://doi.org/10.1186/s12885-019-5716-z.

PMID
31174493
Full Text

Labriola, Matthew K., Kristen A. Batich, Jason Zhu, Megan A. McNamara, Michael R. Harrison, Andrew J. Armstrong, Daniel J. George, and Tian Zhang. “Immunotherapy Is Changing First-Line Treatment of Metastatic Renal-Cell Carcinoma.” Clin Genitourin Cancer 17, no. 3 (June 2019): e513–21. https://doi.org/10.1016/j.clgc.2019.01.017.

PMID
30858035
Full Text

Heath, Elisabeth I., David M. Nanus, Susan Slovin, Chuck Strand, Celestia Higano, Virgil H. Simons, Crawford Johnson, et al. “Prostate Cancer National Summit's Call to Action.” Clin Genitourin Cancer 17, no. 3 (June 2019): 161–68. https://doi.org/10.1016/j.clgc.2019.04.002.

PMID
31085057
Full Text

Robinson, Timothy J., Jennifer A. Freedman, Muthana Al Abo, April E. Deveaux, Bonnie LaCroix, Brendon M. Patierno, Daniel J. George, and Steven R. Patierno. “Alternative RNA Splicing as a Potential Major Source of Untapped Molecular Targets in Precision Oncology and Cancer Disparities.” Clin Cancer Res 25, no. 10 (May 15, 2019): 2963–68. https://doi.org/10.1158/1078-0432.CCR-18-2445.

PMID
30755441
Full Text

Pages